Selling peptides on Facebook Marketplace

Selling peptides on Facebook Marketplace?
Selling peptides on Facebook Marketplace requires a decision about your exact product and offer. Meta prohibits commerce content promoting medical and healthcare products and drugs or prescription products. A research label does not settle intended use. Check the item against Meta's written categories and applicable law before posting; pause a prohibited or unresolved listing. [1][2]
Start with what you would actually offer, not the word peptide. The label, claims, buyer, listing text and route to payment can change the question you need answered. Meta's Commerce Policies apply to attempts to sell or trade on Marketplace, including offers made for free. [1]
The practical outcome may be a documented stop, a request for a specific platform answer, or a review of a mistaken removal. None of those outcomes is an approval to sell. The sections below give you a way to record the facts and identify who must resolve a remaining question.
Key Facts
- Meta defines commerce content as an attempt to buy, sell or trade products, even for free, on named commerce services that include Facebook Marketplace. [1]
- Meta says commerce content may not promote buying, selling or trading medical and healthcare products and services, including medical devices or ingestible supplements. [1]
- Meta separately says commerce content may not promote buying, selling or trading drugs, drug paraphernalia or prescription products. [1]
- Meta says Marketplace is intended for consumer to consumer sales; that stated purpose does not answer whether your specific item fits a prohibited category. [1]
- An FDA warning letter examined a peptide seller's website and Facebook presence and treated research labeling alongside evidence of intended use. [2]
- If Meta rejects or removes commerce content and you believe that decision was mistaken, Meta provides a route to request review. [1]
TL;DR
Define the exact product and proposed activity before drafting a Marketplace listing. Apply Meta's quoted categories to those facts, then get a qualified answer on the product law question. If a category fits or material facts remain unresolved, pause the proposed listing; a different Facebook surface does not itself answer the same commerce question.
The Marketplace decision begins with the item and the activity
Define your exact item and every part of the proposed offer before deciding whether to list it. A category answer given to a vague description cannot reliably govern a listing with different labels, claims or buyers.
Make an intake card for one proposed item, not your whole catalog. Record the product name as it appears on the package, its physical form, the label wording, any accompanying materials and every statement you plan to place in the listing. Keep a copy of the product page or other destination a buyer would see. Note who would be offered the item, what the proposed buyer says they will do with it, and what you would actually promise in a message or invoice. These are inputs for a decision, not wording suggestions for a listing.
Next describe the activity. Is your plan to display a price in Marketplace, invite a buyer to message you, exchange the item without a price, or promote a separate site? Meta defines commerce content by the attempted buying, selling or trading, including free offers. Changing the visible price does not remove the need to classify the activity. [1] The transaction path matters because you need to know which proposed offer, destination and conversation to put before Meta or counsel. It does not give you a way to evade a policy category.
Keep the role of your business precise. A research supply proposal describes one claimed purpose. Patient supply, prescribing and compounding are different activities and should not be silently folded into that proposal. If your materials, prospective buyers or planned fulfillment point toward a different purpose, record the discrepancy and take it to regulatory counsel. A statement of research purpose cannot, by itself, establish the legal status of the offer. The FDA example discussed under why a research label does not settle intended use shows why the complete presentation matters. [2]
An intake card can use these fields:
| Field | Your entry | What the entry resolves |
|---|---|---|
| Exact item | Name, form and label copy | What you want assessed |
| Public statements | Listing text and destination text | What a buyer would read |
| Proposed buyer | Buyer type and stated purpose | Which activity you are proposing |
| Transaction | Offer, message, checkout and delivery path | Where commerce may occur |
| Open question | Exact policy or legal issue | Who must answer it |
For example, a hypothetical seller may have one package marked for laboratory work, a draft listing that gives no intended activity, and a linked page with different descriptions. The correct intake result is not a yes or no based on the package label. It is a complete set of the proposed statements and a flagged discrepancy for review. If the seller changes a material fact later, the earlier assessment no longer describes the offer under consideration.
Where Meta applies its Commerce Policies
Meta's Commerce Policies apply to commerce content on its named commerce services, including Marketplace. Identify the particular service and action you propose before applying a rule to it. [1]
Meta defines commerce content as any attempt to buy, sell or trade products, even for free, on Facebook, Instagram, WhatsApp or Messenger services designed for commerce. Its examples include Facebook Marketplace, Shops on Facebook and Instagram, and WhatsApp Business Catalog; the examples are not an exclusive list. Products offered for sale or trade on those services or features must comply with the Commerce Policies. [1] This is a definition of covered commerce activity, not an invitation to try another surface when a product category is prohibited.
Use the following surface matrix to avoid confusing one decision with another:
| Proposed action | What the quoted Commerce Policies establish | Further question to resolve |
|---|---|---|
| Marketplace listing | Marketplace is a named commerce service; an attempted sale is commerce content. [1] | Does the actual item or offer fit a prohibited category? |
| Shop or catalog offer | Shops and WhatsApp Business Catalog are named examples. [1] | What rules apply to the exact offered product and account? |
| Free product offer | The commerce definition includes offers even for free. [1] | Is the offer within a prohibited category despite no price? |
| Page or group activity | Coverage depends on the actual activity and service, not a reassuring label for the post. [1] | Obtain Meta's current rule for that exact Page or group action. |
| Paid advertisement | A paid ad is a separate action to evaluate. | Obtain readable current Meta Advertising Standards for the creative and destination. |
| Payment function | Payment is a separate function to evaluate. | Ask the provider for its current eligibility decision on the disclosed product. |
The matrix is deliberately about boundaries. It does not say every ordinary Page post is a Marketplace listing, or that a payment service applies the same product classifications. Those propositions require their own current sources. For now, describe each proposed action plainly: what the buyer would see, where they would respond, and which service would handle the next step. Then seek the rule for that action. The underlying commercial offer remains visible in your record even if it passes through several surfaces.
Meta also says buyers, sellers and traders are responsible for applicable laws and other terms that apply to their use of Meta products. [1] Thus a policy assessment and a legal assessment are separate entries on your decision sheet. A favorable response to one question would not itself answer the other. Meta's statement that Marketplace is intended for consumer to consumer sales is another relevant platform fact for a business operator to put on that sheet, not a complete product eligibility rule. [1]
Do this mapping before writing copy. If you first choose a surface and then look for language that seems to fit it, you risk losing the facts that determine which rule actually applies. A complete map helps you ask Meta a narrow question about a specified offer, and helps you see when a provider has answered a different question from the one you asked.
What items are not allowed to be sold on Facebook Marketplace?
Meta prohibits commerce content promoting medical and healthcare products and services, drugs, drug paraphernalia, prescription products, and recalled or banned products. Apply each quoted category to your actual item; the category name alone does not classify every peptide. [1]
The relevant language in Meta's Commerce Policies is specific enough to quote before you make a decision:
| Category to check | Meta's wording | Why it enters your review |
|---|---|---|
| Medical and healthcare | “Commerce content may not promote the buying, selling, or trading of medical and healthcare products and services, including medical devices or ingestible supplements.” [1] | Examine the product, its presentation and the promoted activity. |
| Drugs and prescription products | “Commerce content may not promote the buying, selling, or trading of drugs, drug paraphernalia or prescription products.” [1] | Determine whether the actual product or proposed offer fits these terms. |
| Recalled or banned products | “Commerce content may not promote the buying, selling, or trading of recalled or banned products.” [1] | Check this condition when a product specific fact makes it relevant. |
These are prohibitions on commerce content that promotes the stated activity. Do not read “including” in the medical category as a complete list. Do not infer that an item outside the examples is permitted, or that an item called a research peptide is automatically outside the category. Likewise, the presence of a drug category does not establish that every peptide is a drug. A useful answer needs the exact product and offer, followed by an interpretation of the published words from the relevant authority.
The first practical question is whether the proposed Marketplace text, image and destination would promote a purchase, sale or trade of the item. A listing created for that purpose should be assessed as an offer. The second is whether the item as presented fits any of the quoted categories. If the answer to a category is yes, stop that proposed listing. If the answer depends on an unresolved fact or interpretation, stop while you obtain a direct answer. Do not replace a category description with a softer synonym in the hope that review will read it differently.
Meta's policy also says that a failure to comply with its policies or the law may lead to rejected or removed listings or other content, removal of product tags, or suspension or termination of access to commerce features. [1] Those are stated possible consequences, not a prediction that a particular account will receive a particular action. They explain why the classification should be made before the proposed listing goes live.
Consider two hypothetical records. In the first, the seller's own materials describe the item as a prescription product. That description squarely raises Meta's quoted prescription category. In the second, a seller has an item with a research label but incomplete facts about intended use and classification. The second record is unresolved; it is not cleared by contrast with the first. In either case, the seller needs a decision tied to the actual materials and current rule, rather than a general answer about the word peptide.
This section gives you the written categories to test. The step by step classification record belongs in classifying a proposed peptide listing. Keep the quote attached to the date you checked it so that a later decision remains traceable to the wording you actually used.
Classifying a proposed peptide listing under the prohibited categories
Classify one proposed listing by matching documented item facts to Meta's quoted categories, and mark any unresolved match as a stop. A guess about how an automated review might respond is not a category decision.
Start with an evidence column and a question column. The evidence column contains the exact package and label, the public copy, the linked destination, and the described transaction. The question column contains each relevant policy phrase. Ask whether the proposed commerce content promotes buying, selling or trading a product that falls within that phrase. Record the reason for each yes, no or unresolved answer. “No” means you have a reasoned answer about that quoted phrase; it does not mean Meta has approved the listing or that every other rule has been checked.
The decision tree is short enough to keep beside the draft:
1. Is this an attempt to buy, sell or trade a product on a Meta commerce service, including a free offer? If yes, continue under the Commerce Policies. If you cannot identify the surface or action, complete the activity card first. [1]
2. Does the evidence show a fit with the medical and healthcare wording? If yes, stop the proposed commerce content. If the fit cannot be resolved from the evidence you have, mark it unresolved and stop pending an answer. [1]
3. Repeat the same test for the drugs, drug paraphernalia and prescription products wording. A research label is one input, not the conclusion. [1][2]
4. If product facts raise the recalled or banned products category, check that quoted condition as well. Do not treat a lack of information about that condition as proof that it is clear. [1]
5. Record separate questions for applicable law, any proposed advertisement, and payment. A Commerce Policies analysis cannot decide those other questions. [1]
This process permits three useful dispositions for each question: category fits, category does not appear to fit on the recorded facts, or unresolved. The second disposition is narrower than permission. It says what you concluded under a particular phrase and why. It can change if the product description, buyer, claims, destination, rules or provider response changes. Where classification calls for interpretation of law or the product's intended use, ask regulatory counsel. Where the issue is Meta's application of its policy, ask Meta about the actual proposed offer.
Do not manufacture a clean answer by omitting a relevant document. If a package says one thing and your marketing materials say another, include both in the question. If a supplier gives you a classification, record who made that statement and what evidence they considered, then decide whether you still need an answer from the authority that will judge your activity. Supplier language is an input you may examine, not a substitute for Meta's current policy or a legal opinion about your own offer.
At the end, write the exact proposed disposition in ordinary language: “Stop because this described offer fits the quoted category,” or “Pause because category fit remains unresolved pending Meta's answer.” A positive outcome requires a source and scope you can name. Do not turn a silent response, an unchanged listing screen, or a prior example into a general approval.
Why a research label does not settle intended use
A research use label does not settle how the proposed product and marketing are assessed. In a peptide warning letter, FDA considered both a seller's website and Facebook presence and looked past research labeling to other evidence of intended use. [2]
The FDA letter addressed a specific seller and specific products, so it is an example of the agency's reasoning in that case, not a universal finding about every peptide business. FDA wrote that it had reviewed the seller's website and had also reviewed the seller's Facebook page. [2] That matters to your evidence packet because the proposed offer can be described across more than one surface. A label on a package is not the entire public presentation if other statements accompany it.
The letter expressly noted product labeling that used “RESEARCH USE ONLY” and “INTENDED AS A RESEARCH CHEMICAL ONLY.” It then said evidence from the seller's websites established an intended use different from those labels in that case. [2] You do not need to reproduce the case's product promotion to learn the operational point: gather all of your own public statements before asking for an intended use assessment. A research designation is a claim about purpose. It is not a legal shield and it does not resolve an inconsistent presentation.
FDA has also published a current page stating that it warned companies over unapproved drugs falsely labeled “for research purposes” or “not for human consumption.” [3] This page addresses specified products and agency actions. It supports a warning about relying on labels alone, not a claim that the products in your own inventory have already received the same classification. Give counsel the exact item, all of its materials and the proposed buyers rather than asking whether research products as a class are acceptable.
For your business, keep two questions separate. The platform question is how Meta applies its Commerce Policies to your actual offer. The regulatory question is how the relevant authority would assess the product and its intended use under applicable law. Meta tells users they remain responsible for applicable laws and other terms. [1] An answer on one question does not automatically carry over to the other. This separation is especially important if you supply a research organization and do not supply patients. Your claimed buyer type belongs in the record, but it does not transform a proposed patient supply, prescribing or compounding activity into research supply.
An effective counsel request identifies the discrepancies you found rather than hiding them. Include the package, proposed Marketplace text, any linked site copy, the proposed buyer description and how you would respond to inquiries. Ask which facts counsel considers decisive, what law or agency guidance applies, and whether the proposed activity needs a different structure or must stop. That is a request for a fact specific assessment; this article cannot give the result.
For a focused explanation of the label issue, see the research use only explainer. For additional examples of FDA correspondence, see the warning letter guide. Those resources are further reading, while your own documents remain the material that needs review.
Can you advertise peptides on Facebook
Treat a proposed Facebook advertisement as a separate policy decision before paying to promote it. Exact peptide ad eligibility is UNCONFIRMED as of 2026-10-03 here, so obtain and apply readable current Meta Advertising Standards to your specific ad and destination.
Do not use a Marketplace conclusion as an advertising conclusion. The Marketplace analysis begins with the Commerce Policies and the commerce content you propose. A paid ad adds a creative, a destination, a selected audience and an account context. Each can affect the question you need answered. No specific current Meta ad restriction for peptide products is established by the available policy text for this article. The responsible decision is to hold the ad until the current rule can be read and applied to the complete proposal.
An advertising review card should include the product identity and form, the exact text and image you intend to promote, the destination reached by a click, the account that would run the ad, and the geography where you propose to show it. Attach the current Advertising Standards passage you rely on, the date you checked it, and the policy question you asked Meta. This is an evidence checklist, not a promise that an ad with those fields will pass review.
You can use a short decision statement in your marketing plan: “Advertising eligibility unresolved until the current Meta rule and the complete proposed ad receive review.” That statement lets you budget and schedule without pretending a missing answer is approval. If the ad creative changes after review, reassess the changed version. If the landing page changes, reassess what the ad now promotes. A response about a generic business name is narrower than a response about a particular product offer.
Do not assume that a paid promotion becomes acceptable because a Marketplace listing is absent. Do not describe an item differently in an ad to avoid the policy words you would use in a product record. Consistent disclosure allows Meta and counsel to answer the question you actually have. If a provider says it cannot assess the proposal without additional facts, add those facts and retain the unresolved status until the provider gives a usable answer.
The decision can also be to abandon the proposed ad. You do not need to buy a test campaign merely to learn whether a rule applies. Ask for the written standard, preserve the answer and keep any later ad decision within its stated scope. For a separately sourced review of paid promotion, see the Meta ads guide.
Pages, groups, messages and transaction paths
Moving the same offer to a Page, group or private conversation does not itself resolve a Commerce Policies concern. Map the proposed activity on each surface and seek the current rule for any Page, group or payment function that has not been answered. [1]
Think of the proposed transaction as a sequence of actions rather than a single post. A person could see a public post, send a message, receive a link, and complete payment elsewhere. Record each action exactly. Meta's definition of commerce content covers attempts to buy, sell or trade on named services designed for commerce, even for free, and it expressly names Messenger among the services in its definition. [1] That text is enough to reject the assumption that a private message automatically removes a commercial offer from consideration. It does not establish a separate product rule for every Page or group post.
A simple boundary diagram can be written as five boxes: Marketplace listing; Page or group activity; Messenger exchange; paid ad; payment function. Draw the planned path between boxes. Put the published Commerce Policies next to any covered commerce offer. Put a question mark next to Page, group and payment details that require a current provider answer. Put the advertising question next to any paid promotion. This prevents one favorable or missing answer from being copied across all boxes.
Meta says commerce content on Facebook and Messenger must also comply with Facebook's Community Standards. [1] That is an additional stated obligation; it is not evidence that meeting those standards overrides a Commerce Policies prohibition. Meta also says users are responsible for other applicable terms and laws. [1] Keep those obligations visible in the map instead of collapsing them into one yes or no box.
If you propose taking a conversation off Marketplace, write down exactly what the buyer would be offered before and after that move. Do not use the channel transition as a method for concealing the product or purpose. If the same prohibited commerce offer remains, a different conversation location does not supply the missing permission. For the separate provider questions that arise at checkout, see the payment processing guide.
The unresolved details should be addressed directly: ask Meta how its current rules apply to the proposed Page or group action, and ask the payment provider about the disclosed product, buyer and transaction. A provider response should identify the function it covers. A Page response should not be recorded as payment approval, and a payment response should not be recorded as Marketplace approval.
What to do if a Marketplace listing is removed
If Meta removes a Marketplace listing and you believe its Commerce Policies decision was mistaken, preserve the listing record and request review through Meta's stated path. If your own review shows the proposed offer fits a prohibited category, withdraw it rather than resubmitting it under a changed description. [1]
Meta says a seller who feels that a rejection or removal for a Commerce Policies violation was a mistake can request a review by following its Marketplace steps. It says it will take another look. [1] That is the published route and scope of the promise. The policy passage does not give you a basis to promise restoration, a particular reviewer decision, or a particular time to an answer.
Before asking for review, preserve the exact listing as it appeared, any notice you received, the product label, the destination and the category you believe Meta applied. Write a short explanation of the alleged mistake using the policy words. For example, distinguish a factual mismatch about the item from a disagreement about how the quoted medical category should be read. If you cannot state what was mistaken, the first task is to complete the classification record, not to keep submitting versions of the listing.
Make the appeal versus withdraw decision explicit. Appeal when you have a specific, supportable reason to believe the decision was wrong on the recorded facts. Withdraw when the actual offer fits the published prohibition or the relevant facts have changed so the original listing no longer represents your proposal. If you remain uncertain, pause and seek a platform or counsel answer. Do not treat a successful technical submission of a review request as a decision in your favor.
Keep the notice and your request with the date and the version of the listing. If Meta responds, record exactly what its response covers. A response about one listing is an answer about that listed item and presentation. It should not be copied onto another product, account, ad or transaction path without asking whether the same facts and rules apply. Meta also lists possible consequences beyond removal of one listing, which gives you a reason to resolve the underlying classification before trying again. [1]
The pre-listing decision worksheet
Use one dated worksheet to combine the item record, Meta's exact policy wording and the unresolved legal or provider questions before you post. The worksheet ends with a clear disposition for the proposed offer, not a vague feeling that it seems acceptable.
Create one row per proposed product and offer. If you sell several items with different labels, claims or intended buyers, do not place them in one row and call the group approved. The purpose of the worksheet is to preserve the facts on which a later answer rests. A changed product page or destination may require a new version of the row, even if the package name remains the same.
Use these fields:
| Field | Entry to make before a decision |
|---|---|
| Version and check date | Date, person preparing the record and proposed listing version |
| Item and activity | Exact item, label, buyer, planned text, destination and transaction path |
| Platform rule | Quoted category, URL, date checked and the facts compared with it |
| Category assessment | Fits, does not appear to fit on these facts, or unresolved, with a reason |
| Regulatory question | Exact intended use issue and counsel response, if obtained |
| Advertising question | Proposed ad and current standard or unresolved status |
| Payment question | Disclosed transaction and provider response or unresolved status |
| Disposition | Stop, pause pending a named answer, or proceed only within confirmed scope |
The worksheet can include a small evidence link for every document rather than repeating documents in a spreadsheet cell. Link to the package image, label, listing draft, destination capture, policy quote and provider correspondence. Keep the date with the quote because policies and presentations can change. An internal reviewer should be able to reconstruct why a category was marked yes, no or unresolved without relying on a conversation from memory.
Here is a hypothetical worked decision. A seller has a packaged item described as research material and drafts a Marketplace offer. The draft points to a site whose product wording differs from the package. The seller has not obtained a product specific regulatory assessment or a Meta response about how the quoted categories apply. The worksheet records the package and site text as separate evidence, marks intended use and category fit unresolved, and sets the disposition to pause. It does not convert the package label into permission. A later answer would have to identify the exact materials it assessed before the disposition could change.
Use a second hypothetical to test the opposite branch: the seller's own proposed offer identifies the item as a prescription product. Meta's quoted drugs and prescription products prohibition is the policy entry. [1] The worksheet records a category fit and stops that Marketplace offer. There is no need to replace the visible words with a neutral phrase; the underlying item and activity are the issue. The two examples have different reasons for stopping, so your record should not erase that distinction.
For a reusable evidence record across business decisions, see the compliance operating system guide. The record is useful only when the dates, quoted rules and unresolved questions stay attached to the actual proposal.
Choosing a next channel after the Marketplace decision
If Marketplace is prohibited or unresolved for your proposed offer, choose any next channel only after disclosing the actual product and activity to that channel and obtaining its current answer. A new site or payment route cannot supply a missing legal or Meta decision.
Start with the disposition on your worksheet. If the issue is an identified Meta prohibition, do not move the same commerce content to another Meta surface as a substitute for the stopped listing. If the issue is an unresolved product classification, send the full fact packet to the right authority or counsel. If the issue is advertising or payment, seek that provider's current rule for its own function. The questions may overlap in practice, but the answers have different scopes.
When considering an independent storefront or another platform, ask the provider to evaluate the exact product identity, label, statements, intended buyer and transaction. Ask what part of its service the response covers: a product page, paid promotion, checkout, account opening or a particular geography. Preserve the response in writing if available. Do not treat silence, a generic signup screen or a different seller's experience as your approval.
Make your next channel plan conditional. Write down the questions that must be answered, the person or provider responsible for each answer, and the change in your plan if the answer is adverse. That makes a stop decision operational: you can still organize inventory, copy and counsel review without publishing a sale offer that you have not cleared. For broader channel questions, see the platform policy guide. Related guide: Can You Sell Peptides on TikTok Shop? Commerce Policy Versus Ad Policy.
What to do next
1. Write down the exact item, label, marketing statements, buyer and transaction path in one intake card.
2. Identify whether the proposed action is a Marketplace listing, another commerce surface, an ad or a payment function.
3. Compare the actual item with Meta's quoted medical and healthcare and drug or prescription categories. [1]
4. Pause any listing whose category fit is prohibited or unresolved, and record the source and date checked.
5. Ask regulatory counsel about intended use and the particular product rather than relying on a research label. [2]
6. Obtain readable current advertising and payment rules before using those functions; keep an unanswered question marked unresolved.
7. If a listing was removed and the classification was mistaken, use Meta's review path with the saved listing record. [1]
8. For another channel, disclose the product and intended activity and obtain that platform's current decision before proceeding.
When should you book a peptide business fit call?
Book a fit call when you can bring the product and channel evidence packet but still need to organize the unanswered platform, payment or regulatory questions. Bring the exact label, proposed public copy, destination, buyer description, policy quotes and any provider replies. The call can help you frame the next decisions; it cannot grant platform or legal approval.
Frequently Asked Questions
Can I legally resell an acquired peptide lot?
An acquired lot needs its own resale assessment; prior possession does not decide what your proposed offer may lawfully do. Give regulatory counsel the purchase record, chain of custody, exact identity, label and proposed claims, and ask which requirements apply to that lot and transaction. Keep that legal question distinct from Meta's Commerce Policies check for the proposed Marketplace content. [1]
What is the most profitable thing to sell on Marketplace?
No cited source here supplies a ranking of profitable Marketplace products or earnings for peptide offers. For a hypothetical example, contribution from one permitted sale would equal the sale price minus product cost, fulfillment cost, payment cost and returns cost; the numbers would be your own assumptions until measured. A product's arithmetic does not override a prohibited category or establish that a channel will accept it. [1]
What should I make of Reddit posts about peptide sales on Marketplace?
A Reddit post can describe what someone says happened to their listing, but it cannot answer how the current written rule applies to yours. Record the post as an anecdote if it raises a useful question, then test that question against Meta's current Commerce Policies and your exact item. A reported live listing is not a platform approval for your proposed offer. [1]
What should I ask a peptide marketing agency before hiring it?
Ask the agency to name each proposed channel, the exact claims and destination it would use, and the current policy passages supporting its plan. Ask which account or product approvals it assumes and who will obtain answers when the rule is unclear. Require a written scope that separates copy development from platform, payment and legal decisions, because an agency's proposed campaign does not decide those authorities' questions.
Sources
These sources are the published Meta policy and FDA materials used for the claims above.
1. Meta, Commerce Policies, https://www.facebook.com/policies_center/commerce/, accessed 2026-10-03.
2. U.S. Food and Drug Administration, Warning Letter to Summit Research Peptides, accessed 2026-10-03.
3. U.S. Food and Drug Administration, FDA's Concerns with Unapproved GLP-1 Drugs, accessed 2026-10-03.
Educational and legal disclaimer
This article is educational information only. It is not legal, regulatory, tax, banking, medical, product, import, platform or payment advice. It makes no personal consumption, administration or health outcome claim. Obtain a fact specific answer from the relevant authority, provider or qualified adviser before acting on your proposed product and activity.
Considering outside help? Questions to ask before choosing a peptide business coach